Blood Advances

Evaluating Real-World Treatment Patterns and Outcomes of Mantle Cell Lymphoma

Tuesday, August 9, 2022 - 2:52pm

The ISHLT Chronic Lung Allograft Dysfunction Consensus Criteria Are Applicable to Pulmonary Chronic GVHD

Thursday, August 4, 2022 - 11:14am

Evaluating the Impact of Eligibility Criteria in First-Line Clinical Trials for Follicular Lymphoma: A MER/LEO Cohort Analysis

Wednesday, August 3, 2022 - 1:36pm

Disparities in Trial Enrollment and Outcomes of Hispanic Adolescent and Young Adult Acute Lymphoblastic Leukemia

Tuesday, August 2, 2022 - 9:20am

Idasanutlin Plus Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia: Results of the MIRROS Trial

Monday, August 1, 2022 - 10:35am

<a href="/node/4144" hreflang="en">Multiple myeloma (MM) therapy within a Medicare-insured patient population: Role of care setting and oncologist sub-specialization in hematologic malignancies.</a>

Relative Hypercoagulation Induced by Suppressed Fibrinolysis After Tisagenlecleucel Infusion in Malignant Lymphoma

Friday, July 29, 2022 - 10:40am

$<a href="/node/5858" hreflang="en">Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma</a>$

Causes of Death in Low Grade B-Cell Lymphomas in the Rituximab Era

Thursday, July 21, 2022 - 10:26am

MiR-146b-5p Regulates Il-23 Receptor Complex Expression in Chronic Lymphocytic Leukemia Cells

Tuesday, July 19, 2022 - 10:17am

<a href="/node/12678" hreflang="en">The Clinical Value of miRNA-21 in Cervical Cancer: A Comprehensive Investigation Based on Microarray Datasets</a>

Prediction of Clinical Outcome in CLL Based on Recurrent Gene Mutations, CLL-IPI Variables, and (para) Clinical Data

Tuesday, July 5, 2022 - 11:23am

Outcomes of Elderly DLBCL Patients Treated With R-CHOP: 10-Year Follow-up of the LNH03-6B Trial

Monday, June 27, 2022 - 3:56pm

Subscribe to Blood Advances